Systematic Reviews Added to MSK Collection

Systematic Reviews, an open access journal that encompasses all aspects of the design, conduct and reporting of systematic reviews, has recently been added to the MSK Library collection.  The journal aims to publish high quality systematic review products including:

  • systematic review protocols
  • systematic reviews related to a very broad definition of health
  • rapid reviews
  • updates of already completed systematic reviews, and
  • methods research related to the science of systematic reviews, such as decision modeling Continue reading

International Open Access Week is Here!

International Open Access (OA) Week takes place this year from October 20 to October 26, 2014, with events taking place all over the world to bring attention to what open access means for research and researchers.

The Scholarly Publishing and Academic Resources Coalition (SPARC) announced in early May that the theme would be “Generation Open” highlighting “the importance of students and early career researchers as advocates for change in the short-term, through institutional and governmental policy, and as the future of the Academy upon whom the ultimate success of the Open Access movement depends.” In addition, the “theme will also explore how changes in scholarly publishing affect scholars and researchers at different stages of their careers.” Continue reading

Obesity May Soon be the Leading Preventable Cause of Cancer and more…

  • Obesity may soon replace tobacco use as the leading preventable cause of cancer. MSK’s Dr. Clifford Hudis, chief of breast cancer medicine, predicts that this will happen in a couple of years. Obesity appears to be related to more aggressive breast cancer in postmenopausal women and prostate cancer in men.
  • MSK opened a new 114,000 square foot, $143 million outpatient facility in West Harrison, NY on Oct 6th. The new campus will benefit MSK patients who live in Westchester County, the lower Hudson valley and western Connecticut. They will be able to get the same care that is offered at MSK’s Manhattan location.
  • An MSK study showed that patients under 40 years old may benefit from PET/CT breast imaging. Up until now, this technique has been used only for patients with stage III disease. The study focused on young women with initial diagnoses of stage I to IIIc. The findings indicated that some patients needed to be upstaged to stage III or IV due to unsuspected spread of disease which led to more appropriate treatment. The results need to be confirmed in a clinical trial.